A Next Generation Theranostic PSMA Ligand for 64Cu and 67Cu-Based Prostate Cancer Imaging and Therapy

被引：0
|
作者：
Ponnala, Shashikanth [7 ]
Amor-Coarasa, Alejandro [4 ]
Kelly, James [6 ]
Zia, Nicholas [1 ,2 ]
Clarence, Williams [7 ]
Nikolopoulou, Anastasia [7 ]
Donnelly, Paul [3 ]
Babich, John [5 ]
机构：
[1] Univ Melbourne, Sch Chem, Melbourne, Vic, Australia
[2] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
[4] Weill Cornell Med Coll, Bronx, NY USA
[5] Weill Cornell Med Coll, New York, NY USA
[6] Weill Cornell Med, New York, NY USA
[7] Weill Cornell Med, Radiol, New York, NY USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1005
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Longitudinal PET/CT Imaging of 64Cu for Radiopharmaceutical Therapy Dosimetry
    Merrick, M.
    Dunnwald, L.
    Tiwari, A.
    Sunderland, J.
    Graves, S.
    MEDICAL PHYSICS, 2021, 48 (06)
  • [32] 64Cu-PSMA-BCH: a new radiotracer for delayed PET imaging of prostate cancer
    Liu, Teli
    Liu, Chen
    Zhang, Zhongyi
    Zhang, Ning
    Guo, Xiaoyi
    Xia, Lei
    Jiang, Jinquan
    Xie, Qing
    Yan, Kun
    Rowe, Steven P.
    Zhu, Hua
    Yang, Zhi
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (13) : 4508 - 4516
  • [33] 64Cu-PSMA-BCH: a new radiotracer for delayed PET imaging of prostate cancer
    Teli Liu
    Chen Liu
    Zhongyi Zhang
    Ning Zhang
    Xiaoyi Guo
    Lei Xia
    Jinquan Jiang
    Qing Xie
    Kun Yan
    Steven P. Rowe
    Hua Zhu
    Zhi Yang
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 4508 - 4516
  • [34] In vivo behavior of [64Cu]NOTA-terpyridine platinum, a novel chemo-radio-theranostic agent for imaging, and therapy of colorectal cancer
    Khosravifarsani, Meysam
    Ait-Mohand, Samia
    Paquette, Benoit
    Sanche, Leon
    Guerin, Brigitte
    FRONTIERS IN MEDICINE, 2022, 9
  • [35] 64Cu-DOTHA2-PSMA, a novel theranostic agent for prostate cancer and its preclinical animal evaluation
    Milot, Marie-Christine
    Benesty, Ophelie Belissant
    Dumulon-Perreault, Veronique
    Ait-Mohand, Samia
    Rousseau, Etienne
    Richard, Patrick
    Guarin, Brigitte
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 96-97 : S105 - S105
  • [36] Hypoxia imaging and theranostic potential of [64Cu][Cu(ATSM)] and ionic Cu(II) salts: a review of current evidence and discussion of the retention mechanisms
    Tengzhi Liu
    Morten Karlsen
    Anna Maria Karlberg
    Kathrine Røe Redalen
    EJNMMI Research, 10
  • [37] Hypoxia imaging and theranostic potential of [64Cu][Cu(ATSM)] and ionic Cu(II) salts: a review of current evidence and discussion of the retention mechanisms
    Liu, Tengzhi
    Karlsen, Morten
    Karlberg, Anna Maria
    Redalen, Kathrine Roe
    EJNMMI RESEARCH, 2020, 10 (01)
  • [38] Novel 64Cu Labeled RGD2-BBN Heterotrimers for PET Imaging of Prostate Cancer
    Lucente, Ermelinda
    Liu, Hongguang
    Liu, Yang
    Hu, Xiang
    Lacivita, Enza
    Leopoldo, Marcello
    Cheng, Zhen
    BIOCONJUGATE CHEMISTRY, 2018, 29 (05) : 1595 - 1604
  • [39] Optimized production of 67Cu based on cross section measurements of 67Cu and 64Cu using an 18 MeV medical cyclotron
    Dellepiane, Gaia
    Casolaro, Pierluigi
    Gottstein, Alexander
    Mateu, Isidre
    Scampoli, Paola
    Braccini, Saverio
    APPLIED RADIATION AND ISOTOPES, 2023, 195
  • [40] 68Ga/64CU PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers
    Calabria, Ferdinando
    Pichler, Robert
    Leporace, Mario
    Wolfsgruber, Johannes
    Coscarelli, Pierluigi
    Dunzinger, Andreas
    Schillaci, Orazio
    Cascini, Giuseppe Lucio
    Bagnato, Antonio
    CURRENT RADIOPHARMACEUTICALS, 2019, 12 (03) : 238 - 246
12345